IFF International Flavors & Fragrances, Inc. Common Stock
关于 International Flavors & Fragrances, Inc. Common Stock 公司概况(来自维基百科)
International Flavors & Fragrances Inc. (IFF) is an American corporation that creates products across taste, texture, scent, nutrition, enzymes, cultures, soy proteins, and probiotics categories, which it markets globally. It is headquartered in New York City and has creative, sales, and manufacturing facilities in 44 countries. The company is a member of the S&P 500 index.
阅读更多
International Flavors & Fragrances Inc. (IFF) is an American corporation that creates products across taste, texture, scent, nutrition, enzymes, cultures, soy proteins, and probiotics categories, which it markets globally. It is headquartered in New York City and has creative, sales, and manufacturing facilities in 44 countries. The company is a member of the S&P 500 index.
History
International Flavors & Fragrances was formed in 1958 by the merger between Polak & Schwarz (P&S) and van Ameringen-Haebler.
Origins
Polak & Schwarz was founded in 1889 by Leopold Schwarz, who had an interest in spices, flavors, and fragrances, and his brother-in-law, Joseph Polak in the small Dutch town of Zutphen. P&S quickly grew to 36 sites globally. Arnold Louis (A.L.) van Ameringen was hired by Polak & Schwarz to open P&S's U.S. office in 1917 before losing his job with them. Relieved of his duties, he opened van Ameringen & Co. at 13 Gold Street in Manhattan, took over Morana, Inc. in 1920, and became van Ameringen-Haebler (VAH) in 1929.
Constant Cornelis (Cook) Brummer was a director at Polak & Schwarz during World War II. Because he saved hundreds of Jewish workers' lives, he is compared to Oskar Schindler. He was recognized by Israel as Righteous Among the Nations in January 2017, for risking his own life to save others from the Nazis.
Merger and early growth
The two companies did well through the bulk of the 20th century, despite difficulties for P&S during World War II. While both companies managed flavors and fragrances, Polak & Schwarz had particular strengths in flavors and van Ameringen-Haebler built a powerful reputation in fragrances. In 1958, the two companies announced their merger to become International Flavors & Fragrances Inc. IFF was listed on the New York Stock Exchange in 1964. It was cross listed to the Euronext Paris Market in 2015, becoming the first U.S.-listed company to make use of Euronext Paris Fast Path process.
Research and innovation
In 1968, in conjunction with the Monell Foundation, IFF established the Monell Chemical Senses Center, dedicated to the research of taste and smell.
In 1985, Dr. Braja D. Mookherjee, a scientist at IFF, pioneered Living Flower technology, which changed the way perfumes are created. The technology allows for the most accurate transmission of the scent of real flowers through perfume ingredients. In 1990, IFF broke ground in their R&D facility located in Union Beach, NJ, to develop its 5,000-square-foot greenhouse and botanical garden, which can maintain tropical and subtropical temperature zones for more than 1,300 varieties of exotic plants.
It is home to a miniature rose called "Overnight Scentsation" (also known as the "Space Rose") which was cultivated for experiments in space and left the Earth during a 10-day flight on board the shuttle Discovery (STS-95) in 1998. Low gravity critically altered the fragrance of the rose, which was later commercialized by IFF and Shiseido.
Leadership
Henry G. Walter, Jr., former IFF Chairman, 1962–1985, was a noted philanthropist and prolific writer, who pioneered the field of aromatherapy. He is considered one of the most influential people in the Industry. It has been speculated that he inspired some of the storylines and characters in the book Masters of Sex by Thomas Maier, as well as the Showtime series by the same the name. During World War II, his wife, Rosalind (Palmer) Walter worked on the night shift as a riveter on the Corsair, the F4U Marine gull-winged, fighter airplane, inspiring the song "Rosie the Riveter."
Acquisitions and divestitures (2000–2016)
In 2000, IFF acquired Laboratoire Monique Rémy based in Grasse, France and forms IFF LMR Naturals, strengthening its position in the development and use of raw materials, natural ingredients for fragrances and flavors. In 2000, IFF acquired Bush Boake Allen with its complementary products, technologies, and presence in key markets, making IFF the largest flavor and fragrance house in the world for several years.
In 2014, IFF acquired Aromor Flavors and Fragrances Ltd., a privately held manufacturer and marketer of complex specialty ingredients that are used in fragrances and flavors based in Israel in Kibbutz Givat Oz.
In 2015, IFF announced that it completed the acquisition of Ottens Flavors. This was followed in 2016 with the acquisition of David Michael & Company. Using this merger as a catalyst, they have since launched Tastepoint by IFF to serve dynamic middle-tier customers.
In 2015, IFF acquired Lucas Meyer Cosmetics, a cosmetic actives firm based in Canada that develops, manufactures and markets innovative ingredients for the cosmetic and personal care industry. Lucas Meyer Cosmetics was sold to Clariant in April 2024.
Corporate profile
IFF has creative, sales, and manufacturing facilities in 44 countries and is a member of the S&P 500 Index. IFF is a $10.8 billion market capital company with a global footprint that generated over 75 percent of its 2016 sales outside the United States and 51 percent in the emerging markets. In 2014, the Company celebrated its 125th anniversary year, from the founding of Polak & Schwarz on January 27, 1889 in Zutphen, Netherlands, to the 1958 merger with van Ameringen-Haebler to form IFF. IFF is ranked among Forbes Best Employers.
Frutarom acquisition and shareholders
On May 8, 2018, IFF acquired the Israeli company Frutarom for $7.1 Billion.
Between 2016 and 2018, Kirsten, Finn and Jorn Rausing became the top shareholders of IFF, having bought nearly 20% of the shares via entities in Singapore and Liechtenstein.
Recent transactions (2019–present)
In 2019, IFF announced the merger of IFF and DuPont's Nutrition & Biosciences (N&B) business in a Reverse Morris Trust transaction. The deal values the combined company at $45.4 billion on an enterprise value basis, reflecting a value of $26.2 billion for the N&B business based on IFF's share price as of December 13, 2019.
In December 2022, French private equity firm PAI Partners announced their acquisition of IFF's Savory Solutions Group, which is valued at about $900 million. Upon the deal's completion, the private equity firm rebranded the solutions group as NovaTaste.
In March 2024, it was announced IFF has sold its IFF Pharma Solutions division to the France-based family owned company, Roquette for $2.85 billion.
CEOs
Jon Erik Fyrwald: 2024–present
Frank Clyburn: 2022–2024
Andreas Fibig: 2014–2022
Doug Tough: 2010–2014
Robert Amen: 2006–2009
Fragrances
IFF created many well-known fragrances, including:
Prince Matchabelli's Wind Song (1952), perfumers Ernest Shiftan and Léon Hardy
Estée Lauder's Youth-Dew (1953), perfumer Joséphine Catapano
Estée Lauder's Aramis (1963), perfumer Bernard Chant
Estée Lauder's Estée (1968), perfumer Bethy Bussé
Norman Norell's Norell (1968), perfumer Joséphine Catapano
Clinique's Aromatics Elixer (1971), perfumer Bernard Chant
Estée Lauder's Aliage (1972), perfumer Francis Camail
Jōvan's Jōvan Cologne (but not Jōvan Musk) (1972), perfumer Murray Moscona
Estée Lauder's Private Collection (1973), perfumer Vincent Marcello
Halston's Halston (1975), perfumers Bernard Chant and Max Gavarry
Halston's Z-14 (1976), perfumers Vincent Marcello and Bernard Chant
Ralph Lauren's Polo (1978), perfumer Carlos Benaïm
Ralph Lauren's Lauren (1978), perfumer Bernard Chant
Estée Lauder's White Linen (1978), perfumers Ernest Shiftan and Sophia Grojsman
Antonia Bellanca's Antonia's Flowers's (1984), perfumers Bernard Chant and Joséphine Catapano
Estée Lauder's Beautiful (1985), perfumers Bernard Chant, Carlos Benaïm, Nicholas Calderone, Max Gavarry, and Sophia Grojsman
Estée Lauder/Prescriptives's Calyx (1986), perfumer Sophia Grojsman
Calvin Klein's Eternity (1988), perfumer Sophia Grojsman
Elizabeth Arden's Red Door (1989), perfumers Carlos Benaïm and Olivier Gillotin
Elizabeth Taylor's White Diamonds (1991), perfumers Carlos Benaïm and Olivier Gillotin
Donna Karan's Cashmere Mist (1994), perfumer Nicholas Calderone
Clinique's Happy (1997), perfumers Rodrigo Flores-Roux and Jean-Claude Delville
Fragrance ingredients
Amber scents
Amber Xtreme
Ambermor
Ambermor Ketal Crystal
Ambermor Ketal IPM
Ambermor-Ex
Ambrinol 95
Bornafix
Cashmeran
Cashmeran Velvet
Cetalor
Grisalva
Operanide
Trisamber
Citrus scents
Bergamal
Citral Dimethyl Acetal
Citrolate
Clonal
Dimyrcetol
Dipentene 5100
Herbalime
Hypo-LEM
Limoxal
Myrcenol Super
Myrcenyl Acetate
Nootkatone Crystals
Nootkatone Natural Crystals
Octacetal
Orange Flower Ether
Pamplefleur
Terpinolene 20
Terpinolene 90
Terpinolene 90 PQ
Terpinolene Rectified
Tetrahydro Myrcenol
Valencene
Verbenal
Floral scents
Anisimea
Aquaflora
Auralva
Citronellol 700
Citronellol 950
Citronellyl Propionate
Cyclemax
Damascenone 93% Min.
Damascenone 98% Min.
Damascol
Dihydro Terpineol
Dimethyl Octanol
Dimethyl Phenyl Ethyl Carbinyl Acetate
Fleuramone
Floral Super
Floralozone
Gelsone
Geraniol 600
Geraniol 7030
Geraniol 950 SG
Geraniol 980 Pure
Geranyl Formate
Geranyl Propionate
Helional
Hyacinth Body
Hyacinth Body No. 3
Hydratropic Aldehyde DMA
Hydroxyol
Indolene 50% BB
Jasmal
Jessemal
Kharismal
Kharismal Super
Lavonax
Lilianth
Lindenol
Lyral
Lyrame Super
Meijiff
Melafleur
Methyl Lavender Ketone
Muguesia
Muguet Ald 50% BB
Nerol 900
Peomosa
Phenafleur
Phenoxanol
Phenyl Acetaldehyde Glycerine Acetal
Phenyl Ethyl Benzoate
Phenyl Ethyl Phenyl Acetate
Pseudo Linalyl Acetate
Reseda Body
Rosalva
Rosethyl
Starfleur
Terpineol 900
Terpineol Alpha JAX
Terpineol AP
Terpineol Extra
Terpinol
Tetrahydro Muguol
Violiff
Ylanganate
Fresh scents
Intreleven Aldehyde
Intreleven Aldehyde Special
Maritima (compound)
Myrac aldehyde
Oceanol
Ozofleur
Pino Acetaldehyde
Precyclemone B
Fruity scents
Beta Naphtyl Isobutyl Ether
Cassiffix
Citronellyl Acetate
Citronellyl Formate
CP Formate Aphermate
Cuminyl Acetate
Cyclabute
Cyclemone A
Damascone Alpha
Damascone Beta
Damascone Delta
Dulcinyl Recrystallized
Ethyl Phenyl Glycidate
Fraistone
Fructone
Geranyl acetate A
Geranyl Acetate Extra
Geranyl Acetate Pure
Geranyl Iso Butyrate
Hexalon
Hexyl acetate
Iso Amyl Butyrate
Nectarate
Neryl Acetate JAX
Prenyl Acetate
Terpinyl Acet Jax
Terpinyl Acetate
Terpinyl Acetate Extra
Tropicalia
Undecalactone Gamma Coeur
Vanoris
Green scents
Galbascone 95
Cortex Aldehyde 50% TEC
Galbascone
Galbascone High Alpha
Hexenyl Salicylate CIS-3 (cis-3-hexenyl salicylate)
Iso Cyclo Citral
Liffarome
Melozone
Montaverdi
Syvertal
Vertoliff
Vivaldie
Herbal scents
Canthoxal
Dihydro Cyclacet
Dihydro Terpinyl Acetate
Fleuranil
Herbac
Ocimene
Ocimenyl Acetate
Oxaspirane-819
Pinane
Salicynalva
Unipine 60
Unipine 85
Verdol
Verdone
Leather scents
Isobutyl Quinoline
Musk scents
Ambrettolide
Celestolide
Edenolide
Galaxolide
Galaxolide 50% BB
Galaxolide 50% DEP
Galaxolide 50% DPG
Galaxolide 50% IPM
Galaxolide Undiluted
Hexadecanolide
Luminide
Muscemor
Musk Z 4
Zenolide
Powdery scents
Bicyclononalactone
Spicy scents
Cinnamalva
Cuminyl Alcohol
Iso Cyclo Geraniol
Prismantol
Veraspice
Woody scents
Andrane
Bacdanol
Cupressus funebris wood oil
Cedrafix
Cedramber
Cedryl Acetate
Coniferan Pure
Hexenyl Benzoate CIS-3
Hexyl benzoate
Iso E Super
Karmawood
Koavone
Kohinool
MCK Chinese
MCK SG
Meth Ionone Alpha Extra
Meth Ionone Beta Coeur
Meth Ionone Gamma A Tocopherol
Meth Ionone Gamma Coeur
Meth Ionone Gamma Pure
Mysantol
Orivone
Piconia
Sanjinol
Santaliff
Timbersilk
Tobacarol
Trimofix
Veramoss
Vertofix Coeur
Environmental record
IFF published its first external sustainability report: Sustainability: The Essence of IFF in 2011. In 2012, IFF adopted the 12 Principles of Green Chemistry as an important differentiator in product design and development.
In 2014, IFF opened a 4,000 kilowatt Photovoltaic Solar Installation in New Jersey, which supplies approximately 40 percent of the electricity needs of its Hazlet, NJ fragrances manufacturing and creative center facilities. It has more than 16,000 modules and approximately 1 million solar cells covering 20 acres of IFF property, making IFF a leader in renewable energy in its sector.
In 2015, IFF achieved LEED Silver Certification for its Flavors Creative Center in Indonesia and achieved Roundtable for Sustainable Palm Oil (RSPO) Supply Chain Certification for its facilities in the United States, the United Kingdom and the Netherlands.
In 2015, Coca-Cola, FUJIFILM, International Flavors and Fragrances, Agristo, Cofely and Water Board De Dommel opened a collective wastewater treatment plant on the premises of FUJIFILM in Tilburg, Netherlands. The wastewater treatment plant can process about 10 million litre per day or more than 3.5 billion litre wastewater per year. The plant has a low level of energy consumption and implements the latest technology in the field of water treatment. After treatment, the wastewater is discharged as clean water into the Wilhelmina Canal, making it available for reuse by the four companies, or for another sustainable use in the Tilburg region.
In 2016, IFF was awarded a place on the CDP Climate "A" List for the 2nd year in a row and achieved a 7% year-over-year reduction in GHG emissions intensity. IFF also became the first flavors and fragrances company to join Together for Sustainability (TfS), driving responsible sourcing throughout their supply chain.
In 2016, IFF deployed the industry's first-ever on-site wind turbine at its Tilburg, Netherlands manufacturing facility. It has an output of 2.4 megawatts, producing approximately 6.5 million kWh of renewable electricity per year, which provides up to 30 percent of the site's electricity needs, and when combined with purchased green electricity the facility is powered by 100 percent renewable electricity.
In 2016, IFF released the First-Ever Cradle to Cradle Certified™ Fragrance: PuraVita™. Designed through a mindset of sustainability the fragrance earned IFF a Platinum level Material Health Certificate.
In 2016, IFF and Unilever launched the Vetiver Together Partnership to Improve the Lives of Vetiver Farming Communities in Haiti and strengthen the supply chain. The project is supported by the Enhancing Livelihoods Fund – a partnership between Unilever, Oxfam Great Britain, and the Ford Foundation and is being implemented by Heifer International in Haiti.
IFF is rated gold by EcoVadis for sustainability, which ranks it as a top supplier and partner.
In 2017, IFF, headquartered in Manhattan, New York City, joined the We Are Still In network demonstrating America's enduring commitment to tackling climate change, ensuring a clean energy future, and upholding the Paris Agreement. IFF announced that it joined the American Business Act on Climate Pledge in 2015.
In 2017, International Flavors & Fragrances' South Brunswick, New Jersey facility earned GreenCircle Certified LLC Zero Waste to Landfill facility status, making it the only facility of its kind in the flavor and fragrance industry to achieve GreenCircle's zero waste status.
IFF was recognized as one of the top green companies in the U.S. in the 2016 Newsweek Green Rankings and named on Barron's 100 Most Sustainable Companies List in 2018.
Partnerships
In 2001, IFF collaborated with the Cosmetic Executive Women (CEW) at the Raymond-Poincaré hospital in Garches, France to develop Olfactotherapy, based on the link between smells and memories, which is now used in several hospitals to help patients with brain injuries, stroke victims and Alzheimer's patients with memory impairment or of language.
In 2016, IFF joined the Well Living Lab as a Sustaining Alliance Member. The Well Living Lab is a collaboration of the Mayo Clinic and Delos Innovate Well that is seeking to, among other things, study indoor environments and create healthier indoor spaces.
In 2017, IFF Lucas Meyer Cosmetics invested in Bio ForeXtra to expand its raw material access.
IFF is a member of the European Flavour Association.
Controversies
IFF has been involved in several lawsuits relating to cases of bronchiolitis obliterans allegedly resulting from exposure to diacetyl in butter flavorings by workers at the Gilster-Mary Lee popcorn plant in Jasper, Missouri. The plaintiffs claim the manufacturers knew about the dangers of the butter flavoring used in the popcorn factory but failed to give a warning. The defendants said they were unaware of the risk and suggested there was not enough evidence to prove their product had caused the disease. Several suits have already been settled amounting to almost $53 million in damages.
In the Murray Hill neighborhood of Jacksonville, Florida an IFF plant is accused of emitting a "vile" chemical-like odor for years. The years long complaints over the emissions of the odors from the plant has caused a class-action lawsuit and a cease and desist against the plant.
来源:维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗
IFF 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
IFF 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
10年表现 收入、净利润、利润率和每股收益趋势
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?
盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
财务健康 债务、流动性、偿付能力 — 资产负债表强度
成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
资本效率 资产周转率、库存周转率、应收账款周转率
股息 收益率、派息率、股息历史、5年CAGR
| 除息日 | 金额 |
|---|---|
| 2026年6月18日 | $0.4000 |
| 2026年3月20日 | $0.4000 |
| 2025年12月19日 | $0.4000 |
| 2025年9月29日 | $0.4000 |
| 2025年6月20日 | $0.4000 |
| 2025年3月21日 | $0.4000 |
| 2024年12月20日 | $0.4000 |
| 2024年9月20日 | $0.4000 |
| 2024年6月21日 | $0.4000 |
| 2024年3月21日 | $0.4000 |
| 2023年12月27日 | $0.8100 |
| 2023年9月21日 | $0.8100 |
| 2023年6月22日 | $0.8100 |
| 2023年3月23日 | $0.8100 |
| 2022年12月27日 | $0.8100 |
| 2022年9月22日 | $0.8100 |
| 2022年6月23日 | $0.7900 |
| 2022年3月24日 | $0.7900 |
| 2021年12月27日 | $0.7900 |
| 2021年9月23日 | $0.7900 |
IFF 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
- 强烈买入 7 29.2%
- 买入 11 45.8%
- 持有 6 25.0%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
18 位分析师 · 2026-08-20收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $0.82 | $1.13 | -0.31% |
| 2026年3月31日 | $1.25 | $1.08 | 0.17% |
| 2025年12月31日 | $0.80 | $0.83 | -0.04% |
| 2025年9月30日 | $1.05 | $1.02 | 0.03% |
| 2025年6月30日 | $1.15 | $1.13 | 0.02% |
| 2025年3月31日 | $1.20 | $1.15 | 0.05% |
同行比较(GICS 子行业) 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| IFF | $17.23B | -47.8 | -5.2% | -3.3% | -2.6% | 36.2% |
| SHW | $80.26B | 31.6 | 2.1% | 10.9% | 57.1% | 48.9% |
| ECL | $74.03B | 36.1 | 2.2% | 12.9% | 22.4% | — |
| PPG | $22.89B | 14.8 | 0.19% | 9.9% | 21.4% | — |
| DD | — | -21.6 | 1.9% | -11.4% | -4.2% | — |
| ALB | — | -24.6 | -4.4% | — | — | — |
| RPM | $13.53B | 20.5 | 6.7% | 8.4% | 21.3% | 41.4% |
| SOLS | $7.71B | 32.6 | 3.1% | 6.1% | 10.2% | — |
| ESI | $6.74B | 31.6 | 3.8% | 7.5% | 7.5% | 42.0% |
| NEU | $6.46B | 15.5 | -2.2% | 15.4% | 24.7% | 31.5% |
| EMN | $14.29B | 15.6 | -6.7% | 5.4% | 8.1% | 21.1% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 17
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.89B | $11.48B | $11.48B | $12.44B | $11.66B | $5.08B | $5.14B | $3.98B | $3.40B | $3.12B | $3.02B | $3.09B | |
| Cost of Revenue | $6.95B | $7.36B | $7.80B | $8.29B | $7.92B | $3.00B | $3.03B | $2.29B | $1.93B | $1.72B | $1.67B | $1.73B | |
| Gross Profit | $3.94B | $4.12B | $3.68B | $4.15B | $3.73B | $2.09B | $2.11B | $1.68B | $1.47B | $1.40B | $1.35B | $1.36B | |
| R&D Expense | $694M | $671M | $636M | $603M | $629M | $357M | $346M | $312M | $295M | $259M | $246M | $254M | |
| SG&A Expense | $1.83B | $2.00B | $1.79B | $1.77B | $1.75B | $949M | $876M | $707M | $570M | $573M | $495M | $508M | |
| Operating Income | $-382M | $766M | $-2.11B | $-1.33B | $585M | $566M | $665M | $584M | $553M | $553M | $588M | $592M | |
| Interest Expense | · | · | $380M | $336M | $289M | $132M | $138M | $133M | $65M | $53M | $46M | $46M | |
| Interest Income | $19M | $15M | $5M | $15M | $8M | · | · | · | · | · | · | · | |
| Other Non-op | $-65M | $-182M | $-5M | $26M | $58M | $7M | $30M | $35M | $50M | $24M | $-3M | $3M | |
| Pretax Income | $-412M | $308M | $-2.52B | $-1.62B | $354M | $441M | $557M | $448M | $537M | $524M | $539M | $549M | |
| Income Tax | $-53M | $41M | $69M | $239M | $75M | $74M | $97M | $108M | $241M | $119M | $120M | $135M | |
| Net Income | $-359M | $267M | $-2.59B | $-1.86B | $279M | $367M | $460M | $340M | $296M | $405M | $419M | $415M | |
| EPS (Basic) | $-1.41 | $1.04 | $-10.14 | $-7.32 | $1.11 | $3.25 | $4.05 | $3.81 | $3.73 | $5.07 | $5.19 | $5.09 | |
| EPS (Diluted) | $-1.41 | $1.04 | $-10.14 | $-7.32 | $1.10 | $3.21 | $4.00 | $3.79 | $3.72 | $5.05 | $5.16 | $5.06 | |
| Shares (Basic) | 256,000,000 | 256,000,000 | 255,000,000 | 255,000,000 | 243,000,000 | 112,000,000 | 112,000,000 | 87,551,000 | 79,070,000 | 79,648,000 | 80,449,000 | 80,936,000 | |
| Shares (Diluted) | 256,000,000 | 256,000,000 | 255,000,000 | 255,000,000 | 243,000,000 | 114,000,000 | 113,000,000 | 88,121,000 | 79,370,000 | 79,981,000 | 80,891,000 | 81,494,000 | |
| EBITDA | $580M | $1.78B | $-968M | $-147M | $1.74B | $892M | $989M | $758M | $699M | $670M | $678M | $682M |
资产负债表 28
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $590M | $469M | $703M | $483M | $711M | $650M | $607M | $635M | $368M | $324M | $182M | $479M | |
| Receivables | $1.29B | $1.62B | $1.73B | $1.82B | $1.91B | $929M | $876M | $63M | $664M | $551M | $538M | $494M | |
| Inventory | $1.51B | $2.13B | $2.48B | $3.15B | $2.52B | $1.13B | $1.12B | $1.08B | $649M | $592M | $572M | $569M | |
| Prepaid Expense | $161M | $159M | $184M | $144M | $160M | $100M | $111M | $91M | · | · | · | · | |
| Other Current Assets | $742M | $686M | $875M | $770M | $728M | $342M | $319M | $277M | $215M | $142M | $145M | $141M | |
| Current Assets | $5.59B | $7.97B | $6.29B | $7.43B | $6.99B | $3.06B | $2.94B | $2.94B | $1.90B | $1.61B | $1.44B | $1.71B | |
| PP&E (Net) | $2.69B | $3.74B | $4.24B | $4.20B | $4.37B | $1.46B | $1.39B | $1.24B | $881M | $776M | $733M | $720M | |
| PP&E (Gross) | $4.84B | $6.17B | $6.64B | $6.18B | $6.16B | $2.93B | $2.69B | $2.49B | $2.09B | $1.91B | $1.81B | $1.77B | |
| Accum. Depreciation | $2.15B | $2.43B | $2.40B | $1.98B | $1.79B | $1.47B | $1.30B | $1.25B | $1.21B | $1.14B | $1.08B | $1.05B | |
| Goodwill | $8.23B | $9.07B | $10.63B | $13.37B | $16.43B | $5.59B | $5.50B | $5.38B | $1.16B | $1.00B | $941M | $675M | |
| Intangibles | $3.96B | $6.45B | $8.36B | $9.08B | $10.51B | $2.73B | $2.85B | $3.04B | $416M | $366M | $306M | $77M | |
| Other Non-current Assets | $954M | $907M | $764M | $689M | $616M | $418M | $608M | $289M | $250M | $128M | $118M | $129M | |
| Total Assets | $25.54B | $28.72B | $30.98B | $35.52B | $39.66B | $13.55B | $13.29B | $12.89B | $4.60B | $4.02B | $3.70B | $3.49B | |
| Accounts Payable | $933M | $1.28B | $1.38B | $1.42B | $1.53B | $556M | $510M | $471M | $338M | $275M | $286M | $216M | |
| Short-term Debt | $314M | $0 | $0 | $187M | $324M | $0 | · | · | · | $0 | · | · | |
| Current Liabilities | $3.93B | $4.35B | $3.76B | $3.73B | $3.63B | $1.90B | $1.55B | $1.13B | $769M | $898M | $725M | $519M | |
| Capital Leases | $533M | $550M | $642M | $672M | $670M | $265M | $253M | · | · | · | · | · | |
| Deferred Tax | $840M | $1.59B | $1.94B | $2.28B | $2.52B | $593M | $641M | $656M | $51M | · | · | $12M | |
| Other Non-current Liabilities | $573M | $627M | $560M | $491M | $462M | $268M | $502M | $248M | $191M | $137M | $161M | $118M | |
| Long-term Debt | $5.64B | $8.89B | $9.98B | $10.58B | $10.97B | $4.44B | $4.42B | $4.60B | $1.64B | $1.33B | $1.07B | $942M | |
| Total Debt | $6.31B | $8.98B | $10.07B | $11.16B | $11.72B | $4.41B | $4.38B | $4.55B | $1.64B | $1.33B | $1.07B | $942M | |
| Common Stock | $35M | $35M | $35M | $35M | $35M | $16M | $16M | $16M | $14M | $14M | $14M | $14M | |
| Retained Earnings | $-3.42B | $-2.65B | $-2.44B | $955M | $3.64B | $4.16B | $4.12B | $3.96B | $3.87B | $3.82B | $3.60B | $3.35B | |
| Treasury Stock | $952M | $944M | $963M | $978M | $997M | $1.02B | $1.02B | $1.03B | $1.73B | $1.68B | $1.56B | $1.45B | |
| AOCI | $-1.43B | $-2.53B | $-1.90B | $-2.20B | $-1.42B | $-698M | $-717M | $-702M | $-637M | $-680M | $-613M | $-540M | |
| Stockholders' Equity | $14.15B | $13.83B | $14.61B | $17.66B | $21.08B | $6.31B | $6.22B | $6.03B | $1.68B | $1.63B | $1.59B | $1.52B | |
| Liabilities + Equity | $25.54B | $28.72B | $30.98B | $35.52B | $39.66B | $13.55B | $13.29B | $12.89B | $4.60B | $4.02B | $3.70B | $3.49B | |
| Shares Outstanding | 255,700,000 | 255,700,000 | 255,300,000 | 254,968,463 | 254,573,984 | 106,937,990 | 106,787,299 | 106,619,202 | 78,947,381 | 79,213,037 | 80,022,291 | 80,777,590 |
现金流 19
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $962M | $1.01B | $1.14B | $1.18B | $1.16B | $325M | $323M | $174M | $118M | $102M | $90M | $89M | |
| Stock-based Comp | $88M | $77M | $65M | $49M | $54M | $36M | $34M | $29M | $27M | $25M | $23M | $23M | |
| Deferred Tax | $-270M | $-323M | $-371M | $-237M | $-236M | $-68M | $-59M | $19M | $59M | $14M | $13M | $23M | |
| Amort. of Intangibles | $568M | $610M | $680M | $727M | $732M | $193M | $193M | $76M | $35M | $24M | $15M | $7M | |
| Restructuring | $70M | $29M | $68M | $12M | $41M | $17M | $30M | $5M | $20M | $-1M | $8M | $6M | |
| Other Non-cash | $429M | $35M | $3.16B | $1.27B | $184M | $53M | $-60M | $-125M | $-108M | $-11M | $-111M | $-32M | |
| Operating Cash Flow | $850M | $1.07B | $1.46B | $397M | $1.44B | $714M | $699M | $438M | $391M | $550M | $467M | $518M | |
| CapEx | $594M | $463M | $503M | $504M | $393M | $192M | $236M | $170M | $129M | $126M | $101M | $143M | |
| Investing Cash Flow | $2.27B | $326M | $558M | $745M | $-18M | $-187M | $-226M | $-5.01B | $-300M | $-355M | $-577M | $-221M | |
| Debt Issued | · | · | $0 | $0 | $3M | $200M | $0 | $3.26B | $498M | $556M | $0 | $4M | |
| Net Debt Issued | $-2.91B | $-1.03B | $-655M | $-300M | $-825M | $-147M | $-155M | $2.88B | $248M | $431M | $0 | $4M | |
| Stock Repurchased | $38M | $0 | $0 | · | · | $0 | $0 | $15M | $58M | $127M | $122M | $88M | |
| Net Stock Activity | $-38M | · | · | · | · | $0 | $0 | $-15M | $-58M | $-127M | $-122M | $-88M | |
| Dividends Paid | $409M | $514M | $826M | $810M | $667M | $323M | $314M | $230M | $206M | $185M | $159M | $133M | |
| Financing Cash Flow | $-3.09B | $-1.61B | $-1.85B | $-1.23B | $-1.30B | $-512M | $-505M | $4.87B | $-43M | $-34M | $-165M | $-202M | |
| Net Change in Cash | $119M | $-264M | $183M | $-164M | $56M | $36M | $-25M | $280M | $44M | $142M | $-297M | $73M | |
| Taxes Paid | $329M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $256M | $607M | $936M | $-107M | $1.04B | $522M | $463M | $267M | $262M | $409M | $333M | $375M | |
| Levered FCF | · | · | $549M | $-492M | $816M | $413M | $349M | $167M | $226M | $368M | $297M | $340M |
盈利能力 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 36.2% | 35.9% | 32.1% | 33.4% | 32.0% | 41.0% | 41.1% | 42.3% | 43.5% | 44.9% | 44.7% | 44.1% | |
| Operating Margin | -3.5% | 6.7% | -18.4% | -10.7% | 5.0% | 11.1% | 12.9% | 14.7% | 17.1% | 18.2% | 19.5% | 19.2% | |
| Net Margin | -3.3% | 2.1% | -22.3% | -15.0% | 2.4% | 7.2% | 8.9% | 8.5% | 8.7% | 13.0% | 13.9% | 13.4% | |
| Pretax Margin | -3.8% | 2.4% | -21.9% | -13.1% | 3.0% | 8.7% | 10.8% | 11.3% | 15.8% | 16.8% | 17.8% | 17.8% | |
| EBITDA Margin | 5.3% | 15.5% | -8.4% | -1.2% | 14.9% | 17.5% | 19.2% | 19.1% | 20.6% | 21.5% | 22.4% | 22.1% | |
| ROA | -1.3% | 0.83% | -7.7% | -5.0% | 1.1% | 2.7% | 3.5% | 3.9% | 6.9% | 10.5% | 11.6% | 12.2% | |
| ROE | -2.6% | 1.7% | -15.9% | -9.6% | 2.0% | 5.9% | 7.5% | 8.8% | 17.9% | 25.2% | 27.0% | 27.8% | |
| ROIC | -1.6% | 3.0% | -8.7% | -5.3% | 1.4% | 4.4% | 5.2% | 4.2% | 9.6% | 14.9% | 17.2% | 18.2% |
流动性与偿付能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.8 | 1.7 | 2.0 | 1.9 | 1.6 | 1.9 | 2.6 | 2.5 | 1.8 | 2.0 | 3.3 | |
| Quick Ratio | 0.6 | 0.5 | 0.6 | 0.6 | 0.7 | 0.8 | 0.4 | 0.6 | 0.5 | 0.4 | 0.2 | 0.9 | |
| Debt / Equity | 0.4 | 0.6 | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 0.8 | 1.0 | 0.8 | 0.7 | 0.6 | |
| LT Debt / Equity | 0.3 | 0.5 | 0.6 | 0.6 | 0.5 | 0.6 | 0.6 | 0.7 | 1.0 | 0.7 | 0.6 | 0.6 | |
| Interest Coverage | · | · | -5.6 | -3.9 | 2.0 | 4.3 | 4.8 | 4.4 | 8.9 | 10.7 | 12.8 | 12.9 |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.8 | 0.8 | 0.8 | 0.9 | |
| Inventory Turnover | 3.2 | 3.2 | 2.8 | 2.9 | 4.3 | 2.7 | 2.8 | 2.7 | 3.1 | 3.0 | 2.9 | 3.1 | |
| Receivables Turnover | 6.5 | 6.9 | 6.5 | 6.7 | 8.2 | 5.6 | 82.8 | · | · | · | · | · |
增长率 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -5.2% | 0.04% | -7.7% | 6.7% | 129.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -4.3% | -0.49% | 31.2% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 16.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | · | -65.7% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | -1.8% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | · | -24.0% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | -1.5% | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 4.8% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 17
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10.89B | $11.48B | $11.48B | $12.44B | $11.66B | $5.08B | $5.14B | $3.98B | $3.40B | $3.12B | $3.02B | $3.09B | |
| Net Income TTM | $-359M | $267M | $-2.59B | $-1.86B | $279M | $367M | $460M | $340M | $296M | $405M | $419M | $415M | |
| Market Cap | $17.23B | $21.62B | $20.67B | $26.73B | $38.35B | $11.64B | $13.78B | $14.32B | $12.05B | $9.33B | $9.57B | $8.19B | |
| Enterprise Value | $22.95B | $30.13B | $30.04B | $37.40B | $49.36B | $15.40B | $17.55B | $18.23B | $13.32B | $10.34B | $10.46B | $8.65B | |
| P/E | -47.8 | 81.3 | -8.0 | -14.3 | 137.0 | 33.9 | 32.3 | 35.4 | 41.0 | 23.3 | 23.2 | 20.0 | |
| P/S | 1.6 | 1.9 | 1.8 | 2.1 | 3.3 | 2.3 | 2.7 | 3.6 | 3.5 | 3.0 | 3.2 | 2.7 | |
| P/B | 1.2 | 1.6 | 1.4 | 1.5 | 1.8 | 1.8 | 2.2 | 2.4 | 7.2 | 5.7 | 6.0 | 5.4 | |
| P / Tangible Book | 8.8 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 20.3 | 20.2 | 14.4 | 67.3 | 26.7 | 16.3 | 19.7 | 32.7 | 30.8 | 17.4 | 22.1 | 15.8 | |
| P / FCF | 67.3 | 35.6 | 22.1 | -249.8 | 36.7 | 22.3 | 29.8 | 53.5 | 46.0 | 22.8 | 28.8 | 21.8 | |
| EV / EBITDA | 39.6 | 16.9 | -31.0 | -254.5 | 28.4 | 17.3 | 17.8 | 24.1 | 19.0 | 15.4 | 15.4 | 12.7 | |
| EV / FCF | 89.6 | 49.6 | 32.1 | -349.6 | 47.3 | 29.5 | 37.9 | 68.2 | 50.9 | 25.3 | 31.5 | 23.1 | |
| EV / Revenue | 2.1 | 2.6 | 2.6 | 3.0 | 4.2 | 3.0 | 3.4 | 4.6 | 3.9 | 3.3 | 3.5 | 2.8 | |
| Dividend Yield | 2.4% | 2.4% | 4.0% | 3.0% | 1.7% | 2.8% | 2.3% | 1.6% | 1.7% | 2.0% | 1.7% | 1.6% | |
| Earnings Yield | -2.1% | 1.2% | -12.5% | -7.0% | 0.73% | 2.9% | 3.1% | 2.8% | 2.4% | 4.3% | 4.3% | 5.0% | |
| Payout Ratio | -113.9% | 208.1% | -32.2% | -43.5% | 239.1% | 87.8% | 68.1% | 67.8% | 69.7% | 45.6% | 37.9% | 32.1% | |
| Annual Payout | $409M | $514M | $826M | $810M | $667M | $323M | $314M | $230M | $206M | $185M | $159M | $133M |
损益表 17
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.95B | $2.74B | $2.59B | $2.69B | $1.92B | $2.84B | $2.77B | $2.92B | $2.89B | $2.90B | $2.70B | $2.82B | $2.93B | $3.03B | $2.84B | $3.06B | |
| Cost of Revenue | $1.10B | $1.72B | $1.70B | $1.71B | $1.09B | $1.81B | $1.79B | $1.87B | $1.82B | $1.88B | $1.84B | $1.90B | $2.00B | $2.06B | $1.98B | $2.06B | |
| Gross Profit | $853M | $1.02B | $890M | $983M | $824M | $1.03B | $980M | $1.05B | $1.07B | $1.02B | $860M | $924M | $933M | $964M | $869M | $1.00B | |
| R&D Expense | $170M | $166M | $174M | $174M | $170M | $164M | $170M | $162M | $173M | $166M | $157M | $157M | $161M | $161M | $143M | $145M | |
| SG&A Expense | $437M | $427M | $469M | $421M | $409M | $461M | $517M | $495M | $493M | $490M | $444M | $444M | $445M | $454M | $440M | $413M | |
| Operating Income | $158M | $273M | $97M | $226M | $142M | $-903M | $127M | $249M | $191M | $199M | $-2.54B | $150M | $145M | $131M | $105M | $-1.99B | |
| Interest Expense | $46M | $44M | · | $48M | $61M | $71M | · | $74M | $79M | $83M | · | $90M | $101M | $100M | · | $83M | |
| Interest Income | $4M | $3M | $4M | $4M | $7M | $4M | $6M | $3M | $3M | $3M | $3M | $1M | $1M | $0 | · | · | |
| Other Non-op | $-20M | $-13M | $-21M | $-14M | $-20M | $-20M | $-138M | $-28M | $-15M | $-1M | $-8M | $9M | $11M | $-17M | $-17M | $33M | |
| Pretax Income | $64M | $209M | $-8M | $56M | $438M | $-994M | $-85M | $95M | $183M | $115M | $-2.64B | $59M | $50M | $14M | $-5M | $-2.04B | |
| Income Tax | $31M | $39M | $-13M | $15M | $-112M | $23M | $-60M | $36M | $11M | $54M | $-8M | $32M | $23M | $22M | $19M | $160M | |
| Net Income | $50M | $169M | $7M | $40M | $599M | $-1.02B | $-21M | $58M | $170M | $60M | $-2.63B | $25M | $27M | $-9M | $-18M | $-2.20B | |
| EPS (Basic) | $0.20 | $0.66 | $0.02 | $0.16 | $2.34 | $-3.98 | $-0.09 | $0.23 | $0.67 | $0.23 | $-10.31 | $0.10 | $0.11 | $-0.04 | $-0.11 | $-8.60 | |
| EPS (Diluted) | $0.20 | $0.66 | $0.03 | $0.16 | $2.33 | $-3.98 | $-0.08 | $0.23 | $0.66 | $0.23 | $-10.31 | $0.10 | $0.11 | $-0.04 | $-0.11 | $-8.60 | |
| Shares (Basic) | 255,000,000 | 256,000,000 | -512,000,000 | 256,000,000 | 256,000,000 | 256,000,000 | -510,000,000 | 256,000,000 | 255,000,000 | 255,000,000 | -510,000,000 | 255,000,000 | 255,000,000 | 255,000,000 | -510,000,000 | 255,000,000 | |
| Shares (Diluted) | 257,000,000 | 257,000,000 | -514,000,000 | 257,000,000 | 257,000,000 | 256,000,000 | -513,000,000 | 257,000,000 | 256,000,000 | 256,000,000 | -511,000,000 | 256,000,000 | 255,000,000 | 255,000,000 | -510,000,000 | 255,000,000 | |
| EBITDA | $158M | $519M | · | $226M | $198M | $-667M | · | $249M | $191M | $477M | · | $150M | $145M | $407M | · | $-1.99B |
资产负债表 28
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $569M | $562M | $590M | $621M | $816M | $613M | $469M | $567M | $671M | $732M | $703M | $629M | $638M | $590M | $483M | $538M | |
| Receivables | $1.42B | $1.83B | $1.73B | $1.87B | $1.80B | $1.74B | $1.62B | $1.77B | $1.77B | $1.98B | · | $1.83B | $1.89B | $1.90B | · | $2.03B | |
| Inventory | $1.50B | $2.25B | $2.25B | $2.32B | $2.37B | $2.25B | $2.13B | $2.20B | $2.16B | $2.41B | · | $2.55B | $2.79B | $2.95B | · | $3.12B | |
| Prepaid Expense | $139M | $154M | $170M | $180M | $180M | $213M | $159M | $229M | $217M | $202M | · | $184M | $187M | $163M | · | $348M | |
| Other Current Assets | $706M | $795M | $877M | $911M | $940M | $775M | $686M | $770M | $728M | $771M | · | $890M | $898M | $789M | · | $793M | |
| Current Assets | $9.09B | $5.44B | $5.59B | $5.88B | $5.93B | $8.63B | $7.97B | $8.42B | $8.15B | $6.41B | · | $6.39B | $6.44B | $7.44B | · | $6.49B | |
| PP&E (Net) | $2.67B | $4.00B | $4.03B | $3.87B | $3.90B | $3.77B | $3.74B | $3.77B | $3.76B | $4.14B | · | $4.13B | $4.22B | $4.22B | · | $4.05B | |
| PP&E (Gross) | $4.92B | $6.86B | $6.83B | $6.61B | $6.62B | $6.33B | $6.17B | $6.27B | $6.14B | $6.61B | · | $6.37B | $6.40B | $6.31B | · | $6.03B | |
| Accum. Depreciation | $2.26B | $2.87B | $2.80B | $2.74B | $2.71B | $2.56B | $2.43B | $2.49B | $2.38B | $2.47B | · | $2.24B | $2.19B | $2.08B | · | $1.98B | |
| Goodwill | $8.14B | $8.22B | $8.27B | $8.26B | $8.28B | $8.03B | $9.07B | $9.35B | $9.28B | $10.54B | $10.63B | $13.03B | $13.50B | $13.46B | $13.37B | $13.30B | |
| Intangibles | $3.73B | $5.87B | $6.04B | $6.18B | $6.43B | $6.38B | $6.45B | $6.77B | $6.88B | $8.12B | · | $8.38B | $8.81B | $8.97B | · | $9.39B | |
| Other Non-current Assets | $1.02B | $1.05B | $1.02B | $982M | $955M | $869M | $907M | $968M | $805M | $737M | · | $763M | $754M | $744M | · | $663M | |
| Total Assets | $25.15B | $25.14B | $25.54B | $25.77B | $26.12B | $28.27B | $28.72B | $29.93B | $29.54B | $30.64B | · | $33.40B | $34.46B | $35.47B | · | $34.54B | |
| Accounts Payable | $1.06B | $1.37B | $1.29B | $1.28B | $1.35B | $1.32B | $1.28B | $1.21B | $1.27B | $1.35B | · | $1.11B | $1.23B | $1.20B | · | $1.53B | |
| Short-term Debt | $50M | $154M | $314M | $370M | · | $292M | $0 | $0 | $189M | $836M | · | $0 | $159M | $588M | · | $204M | |
| Current Liabilities | $4.41B | $3.65B | $3.93B | $4.07B | $3.18B | $4.61B | $4.35B | $3.22B | $3.42B | $3.82B | · | $3.68B | $3.93B | $4.87B | · | $3.63B | |
| Capital Leases | · | · | $533M | · | · | · | $550M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $819M | $1.35B | $1.38B | $1.34B | $1.39B | $1.54B | $1.59B | $1.87B | $1.83B | $1.92B | · | $2.13B | $2.18B | $2.23B | · | $2.28B | |
| Other Non-current Liabilities | $551M | $548M | $582M | $611M | $680M | $592M | $627M | $613M | $572M | $527M | · | $475M | $504M | $494M | · | $472M | |
| Long-term Debt | $5.70B | $5.82B | $5.64B | $6.05B | $6.18B | $9.29B | $8.98B | $9.10B | $9.38B | $10.30B | · | $10.30B | $10.57B | $11.29B | · | $10.77B | |
| Total Debt | $5.75B | $5.97B | · | $6.42B | $6.18B | $9.58B | · | $9.10B | $9.57B | $11.13B | · | $10.30B | $10.73B | $11.88B | · | $10.98B | |
| Common Stock | $35M | $35M | $35M | $35M | $35M | $35M | $35M | $35M | $35M | $35M | · | $35M | $35M | $35M | · | $35M | |
| Retained Earnings | $-3.40B | $-3.35B | $-3.42B | $-3.35B | $-3.21B | $-3.73B | $-2.65B | $-2.46B | $-2.41B | $-2.48B | · | $378M | $560M | $739M | · | $1.19B | |
| Treasury Stock | $998M | $986M | $952M | $915M | $917M | $942M | $944M | $945M | $946M | $961M | · | $964M | $966M | $973M | · | $979M | |
| AOCI | $-1.59B | $-1.51B | $-1.43B | $-1.46B | $-1.42B | $-2.12B | $-2.53B | $-1.76B | $-2.31B | $-2.19B | · | $-2.34B | $-1.86B | $-1.89B | · | $-3.19B | |
| Stockholders' Equity | $13.98B | $14.12B | $14.15B | $14.24B | $14.40B | $13.18B | $13.83B | $14.78B | $14.25B | $14.29B | · | $16.98B | $17.62B | $17.76B | · | $16.89B | |
| Liabilities + Equity | $25.15B | $25.14B | $25.54B | $25.77B | $26.12B | $28.27B | $28.72B | $29.93B | $29.54B | $30.64B | · | $33.40B | $34.46B | $35.47B | · | $34.54B | |
| Shares Outstanding | 255,300,000 | 255,200,000 | 255,700,000 | 256,300,000 | 256,300,000 | 255,700,000 | 255,700,000 | 255,700,000 | 255,656,988 | 255,319,533 | · | 255,268,628 | 255,221,731 | 255,067,476 | · | 254,949,630 |
现金流 18
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $218M | $246M | $237M | $247M | $242M | $236M | $243M | $248M | $246M | $278M | $287M | $292M | $287M | $276M | $282M | $293M | |
| Stock-based Comp | $35M | $16M | $16M | $21M | $32M | $19M | $18M | $16M | $25M | $18M | $15M | $18M | $20M | $12M | $12M | $12M | |
| Deferred Tax | $-22M | $-15M | $-57M | $-50M | $-102M | $-61M | $-180M | $-66M | $-68M | $-9M | $-312M | $-32M | $1M | $-28M | $-15M | $-44M | |
| Amort. of Intangibles | $82M | $146M | $134M | $146M | $82M | $143M | $143M | $146M | $153M | $168M | $167M | $170M | $172M | $171M | $175M | $182M | |
| Restructuring | $6M | $6M | $16M | $16M | $20M | $17M | $23M | $1M | $2M | $3M | $7M | $2M | $7M | $52M | $7M | $-4M | |
| Other Non-cash | · | $-159M | · | · | · | $951M | · | · | · | $-248M | · | · | · | $-124M | · | · | |
| Operating Cash Flow | $422M | $257M | $318M | $164M | $241M | $127M | $389M | $345M | $237M | $99M | $660M | $420M | $248M | $127M | $208M | $289M | |
| CapEx | $136M | $165M | $188M | $132M | $95M | $179M | $160M | $103M | $82M | $118M | $113M | $100M | $115M | $175M | $160M | $108M | |
| Investing Cash Flow | $-156M | $23M | $-157M | $-115M | $2.70B | $-157M | $-281M | $-57M | $742M | $-78M | $-80M | $86M | $719M | $-167M | $-142M | $1.23B | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Net Debt Issued | · | $0 | · | · | · | $-16M | · | · | · | $-833M | · | · | · | · | · | · | |
| Stock Repurchased | $36M | $35M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-35M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | $102M | $102M | $103M | $102M | $102M | $102M | $103M | $102M | $102M | $207M | $207M | $206M | $207M | $206M | $206M | $202M | |
| Financing Cash Flow | $-264M | $-301M | $-200M | $-237M | $-2.82B | $169M | $-162M | $-421M | $-1.06B | $40M | $-558M | $-427M | $-944M | $78M | $-142M | $-1.46B | |
| Net Change in Cash | $7M | $-28M | $-31M | $-195M | $166M | $179M | $-98M | $-105M | $-97M | $36M | $73M | $10M | $35M | $65M | $-3M | $-18M | |
| Free Cash Flow | · | $92M | · | · | · | $-52M | · | · | · | $-19M | · | · | · | $-48M | · | · | |
| Levered FCF | · | $56M | · | · | · | $-125M | · | · | · | $-63M | · | · | · | $15M | · | · |
盈利能力 8
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.6% | 37.1% | · | 36.5% | 37.3% | 36.4% | · | 36.0% | 37.0% | 35.3% | · | 32.8% | 31.9% | 31.9% | · | 32.7% | |
| Operating Margin | 8.1% | 10.0% | · | 8.4% | 7.2% | -31.8% | · | 8.5% | 6.6% | 6.9% | · | 5.3% | 5.0% | 4.3% | · | -64.8% | |
| Net Margin | 2.6% | 6.2% | · | 1.5% | 22.1% | -35.8% | · | 2.0% | 5.9% | 2.1% | · | 0.89% | 0.92% | -0.30% | · | -71.7% | |
| Pretax Margin | 3.3% | 7.6% | · | 2.1% | 19.3% | -35.0% | · | 3.2% | 6.3% | 4.0% | · | 2.1% | 1.7% | 0.46% | · | -66.4% | |
| EBITDA Margin | 8.1% | 18.9% | · | 8.4% | 7.2% | -23.5% | · | 8.5% | 6.6% | 16.4% | · | 5.3% | 5.0% | 13.5% | · | -64.8% | |
| ROA | 0.20% | 0.63% | · | 0.14% | 2.2% | -3.5% | · | 0.19% | 0.53% | 0.18% | · | 0.07% | 0.07% | -0.02% | · | -5.9% | |
| ROE | 0.35% | 1.2% | · | 0.28% | 4.3% | -7.4% | · | 0.37% | 1.1% | 0.37% | · | 0.15% | 0.14% | -0.05% | · | -11.5% | |
| ROIC | 0.41% | 1.1% | · | 0.80% | 1.1% | -4.1% | · | 0.66% | 0.75% | 0.42% | · | 0.25% | 0.28% | -0.25% | · | -7.7% |
流动性与偿付能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 1.5 | · | 1.4 | 1.9 | 1.9 | · | 2.6 | 2.4 | 1.7 | · | 1.7 | 1.6 | 1.5 | · | 1.8 | |
| Quick Ratio | 0.5 | 0.7 | · | 0.6 | 0.8 | 0.5 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.5 | · | 0.7 | |
| Debt / Equity | 0.4 | 0.4 | · | 0.5 | 0.4 | 0.7 | · | 0.6 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | |
| LT Debt / Equity | 0.3 | 0.3 | · | 0.3 | 0.4 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | |
| Interest Coverage | 3.4 | 6.2 | · | 4.7 | 3.2 | -12.7 | · | 3.4 | 2.4 | 2.4 | · | 1.4 | 1.2 | 1.2 | · | -23.9 |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.6 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| Receivables Turnover | 1.2 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.5 | · | 1.5 | 1.4 | 1.5 | · | 1.5 |
估值 (TTM) 15
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9.31B | $11.04B | · | $11.07B | $11.30B | $11.43B | · | $11.53B | $11.54B | $11.68B | · | $11.84B | $12.33B | $12.62B | · | $12.67B | |
| Net Income TTM | $858M | $-197M | · | $-308M | $-178M | $-730M | · | $313M | $282M | $103M | · | $-2.15B | $-2.07B | $-1.85B | · | $-1.65B | |
| Market Cap | $20.22B | $18.51B | · | $15.77B | $18.85B | $19.84B | · | $26.83B | $24.34B | $21.95B | · | $17.40B | $20.31B | $23.46B | · | $23.16B | |
| Enterprise Value | $25.40B | $23.92B | · | $21.57B | $24.22B | $28.81B | · | $35.36B | $33.24B | $32.36B | · | $27.07B | $30.40B | $34.75B | · | $33.60B | |
| P/E | 23.6 | -93.0 | · | -50.9 | -103.6 | -27.1 | · | 86.0 | 86.6 | 215.0 | · | -8.1 | -9.8 | -12.7 | · | -14.1 | |
| P/S | 2.2 | 1.7 | · | 1.4 | 1.7 | 1.7 | · | 2.3 | 2.1 | 1.9 | · | 1.5 | 1.6 | 1.9 | · | 1.8 | |
| P/B | 1.4 | 1.3 | · | 1.1 | 1.3 | 1.5 | · | 1.8 | 1.7 | 1.5 | · | 1.0 | 1.2 | 1.3 | · | 1.4 | |
| P / Tangible Book | 9.6 | 561.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | 72.0 | · | · | · | 156.3 | · | · | · | 221.8 | · | · | · | 184.7 | · | · | |
| P / FCF | · | 201.2 | · | · | · | -381.6 | · | · | · | -1155.5 | · | · | · | -488.7 | · | · | |
| EV / EBITDA | 160.8 | 46.1 | · | 95.4 | 122.3 | -43.2 | · | 142.0 | 174.0 | 67.8 | · | 180.5 | 209.7 | 85.4 | · | -16.9 | |
| EV / FCF | · | 260.0 | · | · | · | -554.1 | · | · | · | -1703.0 | · | · | · | -723.9 | · | · | |
| EV / Revenue | 2.7 | 2.2 | · | 1.9 | 2.1 | 2.5 | · | 3.1 | 2.9 | 2.8 | · | 2.3 | 2.5 | 2.8 | · | 2.7 | |
| Earnings Yield | 4.2% | -1.1% | · | -2.0% | -0.97% | -3.7% | · | 1.2% | 1.2% | 0.47% | · | -12.4% | -10.2% | -7.9% | · | -7.1% | |
| Payout Ratio | · | 60.4% | · | · | · | -10.0% | · | · | · | 345.0% | · | · | · | -2288.9% | · | · |
财务报表 损益表、资产负债表、现金流量表 — 年度,近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $10.89B | $11.48B | $11.48B | $12.44B | $11.66B |
| 毛利率 % | 36.2% | 35.9% | 32.1% | 33.4% | 32.0% |
| 营业利润率 % | -3.5% | 6.7% | -18.4% | -10.7% | 5.0% |
| 净收入 | $-359M | $267M | $-2.59B | $-1.86B | $279M |
| 稀释后每股收益 (EPS) | $-1.41 | $1.04 | $-10.14 | $-7.32 | $1.10 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.4 | 0.6 | 0.7 | 0.6 | 0.6 |
| 流动比率 | 1.4 | 1.8 | 1.7 | 2.0 | 1.9 |
| 速动比率 | 0.6 | 0.5 | 0.6 | 0.6 | 0.7 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $256M | $607M | $936M | $-107M | $1.04B |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存,并会跟随您浏览所有股票。
机构持有人 (13F) 820 家申报者 · $16.9B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 118 (+14 与上一季度对比) | 50 (-29 与上一季度对比) | 273 (+3 与上一季度对比) | 228 (+28 与上一季度对比) | +13.9M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。
公司内部人士 98 位内幕人士 · 27 位高管 · 9 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Richard A Goldstein | Chairman & CEO | 2006年5月5日 M | 213674 | 0 | 0 | $0 |
| Alison A Cornell | EVP & CFO | 2016年5月2日 A | 5422 | 0 | 0 | $0 |
| Kevin C Berryman | EVP & Chief Financial Officer | 2014年12月15日 A | 56105 | 0 | 0 | $0 |
| Douglas J Wetmore | Senior VP, CFO and Treasurer | 2008年8月28日 A | 82518 | 0 | 0 | $0 |
| Hernan Vaisman | Group President, Flavors | 2014年3月27日 A | 22485 | 0 | 0 | $0 |
| Gail S Belmuth | President Corp. Comm. | 2005年1月25日 A | 2616 | 0 | 0 | $0 |
| Angelica T. Cantlon | EVP, Chief Human Resources | 2016年5月2日 A | 37542 | 0 | 0 | $0 |
| Ahmet Baydar | EVP, Research & Development | 2016年3月31日 M | 24869 | 0 | 0 | $0 |
| Douglas D. Tough | Chairman of the Board | 2014年12月1日 M | 218050 | 0 | 0 | $0 |
| Beth Ford | EVP, Supply Chain | 2011年12月22日 A | 38573 | 0 | 0 | $0 |
| Dennis M Meany | SVP, Gen. Counsel & Sec'y | 2010年12月22日 A | 64700 | 0 | 0 | $0 |
| Kimberly A. Hendricks | Controller | 2009年6月30日 J | 2208 | 0 | 0 | $0 |
| Steven J Heaslip | Senior VP Human Resources | 2009年6月30日 A | 51148 | 0 | 0 | $0 |
| Joseph Faranda | Chief Marketing Officer | 2009年2月16日 F | 15044 | 0 | 0 | $0 |
| James H Dunsdon | Chief Transition Officer | 2007年12月20日 A | 43904 | 0 | 0 | $0 |
| James P Huether | Corporate Controller | 2007年5月11日 M | 15702 | 0 | 0 | $0 |
| Clint D Brooks | Senior VP, R & D | 2007年1月11日 M | 47527 | 0 | 0 | $0 |
| Arun Bewoor | VP, Regional Manager | 2006年12月15日 M | 3000 | 0 | 0 | $0 |
| Charles D Weller | VP and Treasurer | 2006年12月14日 M | 7944 | 0 | 0 | $0 |
| Christopher Gibson | VP Global Accounts | 2006年12月11日 M | 5704 | 0 | 0 | $0 |
| Robert Burns | Sr.VP, Regional Manager | 2006年11月15日 M | 390 | 0 | 0 | $0 |
| Dennis Wall | Regional Manager | 2006年11月10日 M | 369 | 0 | 0 | $0 |
| Rob J M Edelman | VP and Regional Manager | 2006年11月7日 S | 3410 | 0 | 0 | $0 |
| Wayne D Howard | EVP Global Operations | 2006年1月24日 A | 3508 | 0 | 0 | $0 |
| Graciela M Ferro | VP Global Accounts | 2005年3月17日 M | 3187 | 0 | 0 | $0 |
| Neil Humphreys | Vice President | 2004年2月17日 M | 2832 | 0 | 0 | $0 |
| Stephen A Block | Senior Vice President | 2003年12月23日 A | 7694 | 0 | 0 | $0 |
| Michael J Cook | 董事 | 2015年5月1日 M | 1755 | 0 | 0 | $0 |
| Arthur C Martinez | 董事 | 2015年5月1日 M | 2405 | 0 | 0 | $0 |
| Margaret Hayes Adame | 董事 | 2012年5月1日 M | 21688 | 0 | 0 | $0 |
| Peter A Georgescu | 董事 | 2011年5月3日 M | 40825 | 0 | 0 | $0 |
| Burton M Tansky | 董事 | 2010年4月27日 M | 8143 | 0 | 0 | $0 |
| Gunter Blobel MD PHD | 董事 | 2009年4月28日 M | 13855 | 0 | 0 | $0 |
| William D Van Dyke III | 董事 | 2003年9月30日 A | — | 0 | 0 | $0 |
| Winder Investment Pte Ltd | 10% 所有者 | 2019年2月21日 P | 20300000 | 0 | 0 | $0 |
| Marc Birenkrant | — | 2026年8月7日 S | 3446 | 0 | 1 | $-85000 |
| Michael Deveau | — | 2026年8月6日 S | 5199 | 0 | 1 | $-754979 |
| Paul J Fribourg | — | 2026年6月1日 P | 2682730 | 8 | 4 | $31275738 |
| De Mendonca Ana Paula Teles | — | 2026年5月4日 M | 5718 | 0 | 0 | $0 |
| Ralf Finzel | — | 2026年5月4日 M | 17621 | 0 | 0 | $0 |
| Deborah Borg | — | 2026年5月4日 M | 37925 | 0 | 0 | $0 |
| Yuvraj Arora | — | 2026年5月1日 M | 17283 | 0 | 0 | $0 |
| Kevin O'Byrne | — | 2026年5月1日 M | 17571 | 0 | 0 | $0 |
| Jesus B Mantas | — | 2026年5月1日 A | — | 0 | 0 | $0 |
| Dawn C Willoughby | — | 2026年5月1日 A | 434 | 0 | 0 | $0 |
| Virginia Drosos | — | 2026年5月1日 M | 2434 | 0 | 0 | $0 |
| Mehmood Khan | — | 2026年5月1日 M | 7173 | 0 | 0 | $0 |
| Brett Icahn | — | 2026年5月1日 M | 34712 | 0 | 0 | $0 |
| Richard Mulligan | — | 2026年5月1日 M | 1712 | 0 | 0 | $0 |
| Erik J Fyrwald | — | 2026年5月1日 M | 109676 | 2 | 0 | $995179 |
来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖
激进投资者及 5%+ 股东 5 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Winder Investment Pte Ltd, Haldor Foundation, Freemont Capital Pte. Ltd. ×7 申报 | 2022年2月4日 | — | 初始申报 | — | SEC |
| Henry P. van Ameringen ×3 申报 | 2006年5月18日 | — | 初始申报 | — | SEC |
| George Rowe, Jr. ×2 申报 | 2004年5月26日 | — | 初始申报 | — | SEC |
| 未披露的报告人 | 2002年12月18日 | — | 初始申报 | — | SEC |
| 未披露的报告人 | 2002年12月18日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 154 只交易所交易基金持有
权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| ANEW · ProShares Trust | 2.32% | 2356 NS | 2026年5月31日 | N-PORT |
| AMID · EA Series Trust | 1.87% | 25751 NS | 2026年5月29日 | N-PORT |
| UYM · ProShares Trust | 1.73% | 9090 NS | 2026年5月31日 | N-PORT |
| FXZ · First Trust Exchange-Traded Alpha... | 1.54% | 84008 NS | 2026年4月30日 | N-PORT |
| FMAT · FIDELITY COVINGTON TRUST | 1.15% | 98987 NS | 2026年4月30日 | N-PORT |
| SZNE · Pacer Funds Trust | 1.04% | 1987 NS | 2026年4月30日 | N-PORT |
| MMID · MFS Active Exchange Traded Funds ... | 1.00% | 4494 NS | 2026年5月31日 | N-PORT |
| FEGE · RBB Fund Trust | 0.84% | 214489 NS | 2026年5月31日 | N-PORT |
| NUDV · Nushares ETF Trust | 0.80% | 5155 NS | 2026年4月30日 | N-PORT |
| ABCS · EA Series Trust | 0.65% | 974 NS | 2026年5月29日 | N-PORT |
| RCGE · EA Series Trust | 0.48% | 6360 NS | 2026年4月30日 | N-PORT |
| SMIZ · Zacks Trust | 0.42% | 14093 NS | 2026年5月31日 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund ... | 0.34% | 21301 NS | 2026年4月30日 | N-PORT |
| NULV · Nushares ETF Trust | 0.33% | 97465 NS | 2026年4月30日 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0.19% | 10256 NS | 2026年5月31日 | N-PORT |
| GSEW · Goldman Sachs ETF Trust | 0.18% | 42327 NS | 2026年5月31日 | N-PORT |
| FEUS · FlexShares Trust | 0.14% | 2166 NS | 2026年4月30日 | N-PORT |
| LRND · New York Life Investments ETF Trust | 0.11% | 4311 NS | 2026年4月30日 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund ... | 0.09% | 5920 NS | 2026年4月30日 | N-PORT |
| EQL · ALPS ETF Trust | 0.09% | 15730 NS | 2026年5月31日 | N-PORT |
| ESG · FlexShares Trust | 0.07% | 1333 NS | 2026年4月30日 | N-PORT |
| JFLI · J.P. Morgan Exchange-Traded Fund ... | 0.07% | 457 NS | 2026年4月30日 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.06% | 132255 NS | 2026年4月30日 | N-PORT |
| SCHV · SCHWAB STRATEGIC TRUST | 0.06% | 129406 NS | 2026年5月31日 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.06% | 17954 NS | 2026年4月30日 | N-PORT |
| FNDX · SCHWAB STRATEGIC TRUST | 0.06% | 200590 NS | 2026年5月31日 | N-PORT |
| USSG · DBX ETF Trust | 0.06% | 4332 NS | 2026年5月29日 | N-PORT |
| HLAL · Listed Funds Trust | 0.06% | 6906 NS | 2026年5月31日 | N-PORT |
| GVUS · Goldman Sachs ETF Trust | 0.06% | 3074 NS | 2026年5月31日 | N-PORT |
| SPXD · DBX ETF Trust | 0.06% | 50 NS | 2026年5月31日 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0.06% | 9641 NS | 2026年5月31日 | N-PORT |
| SNPE · DBX ETF Trust | 0.05% | 18529 NS | 2026年5月29日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.05% | 320999 NS | 2026年4月30日 | N-PORT |
| SPXT · ProShares Trust | 0.05% | 1716 NS | 2026年5月31日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.05% | 2744 NS | 2026年4月30日 | N-PORT |
| XMAG · Tidal Trust II | 0.04% | 838 NS | 2026年5月31日 | N-PORT |
| WRND · New York Life Investments ETF Trust | 0.04% | 64 NS | 2026年4月30日 | N-PORT |
| DEUS · DBX ETF Trust | 0.04% | 1441 NS | 2026年5月29日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.04% | 16906 NS | 2026年4月30日 | N-PORT |
| DSPY · Tema ETF Trust | 0.04% | 4697 NS | 2026年5月31日 | N-PORT |
| JUST · Goldman Sachs ETF Trust | 0.04% | 2921 NS | 2026年5月31日 | N-PORT |
| USCA · DBX ETF Trust | 0.04% | 15010 NS | 2026年5月29日 | N-PORT |
| DFLV · Dimensional ETF Trust | 0.03% | 29166 NS | 2026年4月30日 | N-PORT |
| AVLC · AMERICAN CENTURY ETF TRUST | 0.03% | 5721 NS | 2026年5月31日 | N-PORT |
| SPXN · ProShares Trust | 0.03% | 358 NS | 2026年5月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.03% | 54606 NS | 2026年4月30日 | N-PORT |
| SPXV · ProShares Trust | 0.03% | 174 NS | 2026年5月31日 | N-PORT |
| XRMI · Global X Funds | 0.03% | 227 NS | 2026年4月30日 | N-PORT |
| XCLR · Global X Funds | 0.03% | 15 NS | 2026年4月30日 | N-PORT |
| XYLG · Global X Funds | 0.03% | 294 NS | 2026年4月30日 | N-PORT |